title: Transport of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid and its acyl glucuronide by human intestinal Caco-2 cells.
abstract: 5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a potent cytokine inducer, exhibited marked antitumor activity when given as multiple oral doses in mice. The aim of this study was to examine the transport of DMXAA and its acyl glucuronide (DMXAA-G) using the human Caco-2 cells. DMXAA was minimally metabolized by Caco-2 cells and both DMXAA and DMXAA-G were taken up to a minor extent by the cells. The permeability coefficient (Papp) values of DMXAA over 10-500 microM were 4x10(-5) cm/s to 4.3x10(-5) cm/s for both apical (AP) to basolateral (BL) and BL-AP transport, while the Papp values for the BL to AP flux of DMXAA-G were significantly greater than those for the AP to BL flux, with Rnet values of 4.5-17.6 over 50-200 microM. The BL to AP active efflux of DMXAA-G followed Michaelis-Menten kinetics, with a Km of 83.5+/-5.5 microM, and Vmax of 0.022+/-0.001 nmol/min. The flux of DMXAA-G was energy and Na+-dependent and MK-571 significantly (P<0.05) inhibited its BL to AP flux, with an estimated Ki of 130 microM. These data indicate that the transport of DMXAA across Caco-2 monolayers was through a passive process, whereas the transport of DMXAA-G was mediated by MRP1/2.
authors.affiliation: Department of Pharmacy, Faculty of Science, National University of Singapore, Block S4, 18 Science Drive 4, S 117543, Singapore. phazsf@nus.edu.sg
authors.forename: Shufeng
authors.initials: S
authors.lastname: Zhou
authors.forename: Xia
authors.initials: X
authors.lastname: Feng
authors.forename: Philip
authors.initials: P
authors.lastname: Kestell
authors.forename: James W
authors.initials: JW
authors.lastname: Paxton
authors.forename: Bruce C
authors.initials: BC
authors.lastname: Baguley
authors.forename: Eli
authors.initials: E
authors.lastname: Chan
mesh_terms: D000255:Adenosine Triphosphate / Q000037:antagonists & inhibitors; D000970:Antineoplastic Agents / Q000493:pharmacokinetics*; D001692:Biological Transport; D018938:Caco-2 Cells; D004355:Drug Stability; D020719:Glucuronides / Q000493:pharmacokinetics*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D013696:Temperature; D044004:Xanthones / Q000493:pharmacokinetics* / Q000494:pharmacology
chemical_list: D000970:Antineoplastic Agents; D020719:Glucuronides; D044004:Xanthones; C066668:vadimezan; D000255:Adenosine Triphosphate